- Investing Ideas
- /
- Taiwanese Pharmaceuticals & Biotech High Return On Equity, Low Debt
Taiwanese Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
3
0 new
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
3 companies
Ever Supreme Bio Technology
Market Cap: NT$16.4b
Engages in the research, development, and manufacture of drug products related to human mesenchymal stem cells and immune cells in Taiwan.
6712
NT$187.00
7D
4.8%
1Y
10.6%
PharmaEngine
Market Cap: NT$9.7b
A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.
4162
NT$67.20
7D
-0.3%
1Y
-25.3%
Winston Medical Supply
Market Cap: NT$2.0b
Winston Medical Supply Co.,Ltd. develops, manufactures, and distributes pharmaceuticals, nutrition supplements, and cosmeceutical products in Taiwan and internationally.
6817
NT$112.00
7D
-0.4%
1Y
20.7%